Related Experiment Video

Updated: Mar 29, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

14.0K

Bortezomib inhibits cell proliferation in prostate cancer

Ren-Ping Zheng1, Wei Wang2, Chuan-Dong Wei3

  • 1Department of Urology, First People's Hospital of Jiujiang, Jiujiang, Jiangxi 332000, P.R. China ; Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

Experimental and Therapeutic Medicine
|December 2, 2015
PubMed

Insights

Bortezomib effectively inhibits prostate cancer cell growth by inducing apoptosis. This anticancer drug increases cell death and alters cell cycle phases, offering a potential new treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer outcomes remain poor despite advancements in chemotherapy.
  • There is a critical need for novel anticancer drugs to improve patient survival.

Purpose of the Study:

  • To investigate the inhibitory effects of bortezomib on DU145 prostate cancer cells.
  • To elucidate the mechanisms underlying bortezomib's action on these cells.

Main Methods:

  • MTT assay to assess cell proliferation.
  • Flow cytometry for cell cycle distribution and apoptosis analysis.
  • Western blotting to measure Bik and active-caspase-3 expression.

Main Results:

  • Bortezomib inhibited DU145 cell proliferation in a time- and dose-dependent manner.
  • Treatment led to increased G0/G1 phase arrest, elevated apoptosis, and enhanced expression of Bik and active-caspase-3.
  • Morphological changes indicative of apoptosis were observed.

Conclusions:

  • Bortezomib demonstrates significant inhibitory effects on DU145 prostate cancer cells.
  • Apoptosis induction, potentially mediated by Bik and active-caspase-3 upregulation, is a key mechanism.
  • Bortezomib represents a promising agent for prostate cancer therapy.
Keywords:
apoptosisbortezomibprostate cancer

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.2K
Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons09:27

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

716

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K